Patient and physician preferences for type 2 diabetes medications: a systematic review

被引:30
|
作者
Toroski, Mahdi [1 ]
Kebriaeezadeh, Abbas [1 ,2 ,3 ]
Esteghamati, Alireza [4 ]
Karyani, Ali Kazemi [5 ]
Abbasian, Hadi [1 ]
Nikfar, Shekoufeh [1 ]
机构
[1] Univ Tehran Med Sci, Dept Pharmacoecon & Pharmaceut Adm, Fac Pharm, Tehran, Iran
[2] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Tehran, Iran
[3] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Vali Asr Hosp, Endocrinol & Metab Res Ctr EMRC, Tehran, Iran
[5] Kermanshah Univ Med Sci, Sch Publ Hlth, Kermanshah, Iran
关键词
Patient preferences; Diabetes type 2; Physician; Systematic review; DISCRETE-CHOICE EXPERIMENT; WILLINGNESS-TO-PAY; ADHERENCE; MELLITUS; MANAGEMENT; PEOPLE; HEALTH; ATTRIBUTES; COMPLICATIONS; IMPROVEMENTS;
D O I
10.1007/s40200-019-00449-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There are several treatments to cure type 2 diabetes (T2D) and every one of them has certain attributes which is lead patients and specialists to have different preferences and select power. Therefore, we did this systematic study to evaluate patients and physicians preferences for type 2 diabetes medications by extracting attributes of anti-diabetic medications and identifying their relative importance. Methods We searched the PubMed, Ovid, Web of science, Scopus and Embase databases for articles which have been published on or before May 8th, 2018(The start time of the search in our study was May 8th, 2018). Results The searches identified 3346 studies, of which 17 (from 2009 to 2017) were included in the final synthesis and 27 attributes of type 2 anti-diabetic have been investigated. The most important attributes are changes of blood glucose and HbA1c level, hypoglycemia events, weight changes, gastrointestinal complications, cardiovascular effects, medicines cost, and administration mode and dosage of medicines. Conclusion physicians and patients prefer antidiabetics which is reduce blood glucose and HbA1c level effectively and have low side effects too (hypoglycemic event, cardiovascular and gastrointestinal). The effect of weight reduction, low cost, low dosing and low frequency of using. Health care providers, Specialist, and manufacturers should consider to these attributes in treatment process and marketing. It can increase adherence to management approaches, and reduce morbidity of patients with type 2 diabetes.
引用
收藏
页码:643 / 656
页数:14
相关论文
共 50 条
  • [1] Patient and physician preferences for type 2 diabetes medications: a systematic review
    Mahdi Toroski
    Abbas Kebriaeezadeh
    Alireza Esteghamati
    Ali Kazemi Karyani
    Hadi Abbasian
    Shekoufeh Nikfar
    Journal of Diabetes & Metabolic Disorders, 2019, 18 : 643 - 656
  • [2] Patient Preferences for Noninsulin Diabetes Medications: A Systematic Review
    Purnell, Tanjala S.
    Joy, Susan
    Little, Emily
    Bridges, John F. P.
    Maruthur, Nisa
    DIABETES CARE, 2014, 37 (07) : 2055 - 2062
  • [3] A SYSTEMATIC REVIEW OF PATIENT PREFERENCES FOR SUBCUTANEOUS MEDICATIONS
    Ridyard, C.
    Dawoud, D.
    Hughes, D. A.
    VALUE IN HEALTH, 2013, 16 (07) : A335 - A336
  • [4] PATIENTS' PREFERENCES FOR ANTIHYPERGLYCEMIC MEDICATIONS FOR TYPE 2 DIABETES: A SYSTEMATIC REVIEW OF DISCRETE CHOICE EXPERIMENT
    Banjara, B.
    Emory, L. A.
    Poudel, N.
    Qian, J.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2021, 24 : S86 - S86
  • [5] Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review
    Joy, Susan M.
    Little, Emily
    Maruthur, Nisa M.
    Purnell, Tanjala S.
    Bridges, John F. P.
    PHARMACOECONOMICS, 2013, 31 (10) : 877 - 892
  • [6] Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review
    Susan M. Joy
    Emily Little
    Nisa M. Maruthur
    Tanjala S. Purnell
    John F. P. Bridges
    PharmacoEconomics, 2013, 31 : 877 - 892
  • [7] Patient Preferences Informing Choice of Second-Line Type 2 Diabetes Medications
    Golembiewski, Elizabeth
    Garcia, Andrea E.
    Polley, Eric
    Umpierrez, Guillermo
    Galindo, Rodolfo J.
    Brito, Juan
    Montori, Victor M.
    Mickelson, Mindy
    Mccoy, Rozalina G.
    DIABETES, 2023, 72
  • [8] PATIENT PREFERENCES FOR SECOND-LINE MEDICATIONS TO MANAGE TYPE 2 DIABETES MELLITUS
    Ozdemir, Semra
    Baid, Drishti
    Verghese, Naina
    Lam, Amanda Yun Rui
    Lee, Phong Ching
    Ying, Lim Adoree Yi
    Zhu, Ling
    Finkelstein, Eric A.
    Goh, Su-Yen
    MEDICAL DECISION MAKING, 2020, 40 (01) : E286 - E287
  • [9] Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment
    Ozdemir, Semra
    Baid, Drishti
    Verghese, Naina R.
    Lam, Amanda Y. R.
    Lee, Phong Ching
    Lim, Adoree Y. Y.
    Zhu, Ling
    Ganguly, Sonali
    Finkelstein, Eric A.
    Goh, Su-Yen
    VALUE IN HEALTH, 2020, 23 (07) : 842 - 850
  • [10] Patient and physician preferences regarding medications for HIV treatment
    Lloyd, A.
    Collomb, D.
    Hearn, S.
    Ali, S.
    Mughal, F.
    HIV MEDICINE, 2013, 14 : 55 - 56